Table 3. Treatment regimens and mortality rates in patients who received adequate treatment.

a,d: p=0.2, p=0.5; a,b: p=0.6, p=0.6; a,c: p=0.7, p=0.1; b,c: p=1,p=0.32; b,d: p=0.4,p=0.3  c,d: p=0.6, p=0.1 (p values are provided for 14th and 30th-day mortality)

TMP/SMX: Trimethoprim/sulfamethoxazole, LEV: Levofloxacin

Treatment	Number of patients	14th-day mortality n (%)	30th-day mortality n (%)
TMP/SMX + LEVᵅ	38	7 (18.4)	16 (42.1)
Regimens including TMP/SMX (except LEV)ᵇ	49	11 (22.4)	18 (36.7)
Regimens including LEV (except TMP/SMX) c	17	4 (23.5)	4 (23.5)
Other adequate treatment regimens without TMP/SMX or LEVᵈ	11	4 (36.3)	6 (54.5)
Total	115	26 (22.6)	44 (38.2)